Evidence map›Paper›PMID 35743357›Full record

ArticleJournal of clinical medicine2022

Machine Learning Consensus Clustering of Morbidly Obese Kidney Transplant Recipients in the United States.

Charat Thongprayoon, Shennen A Mao, Caroline C Jadlowiec, Michael A Mao, Napat Leeaphorn, Wisit Kaewput, Pradeep Vaitla, Pattharawin Pattharanitima, Supawit Tangpanithandee, Pajaree Krisanapan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Charat ThongprayoonDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA.
Shennen A MaoDivision of Transplant Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
Caroline C JadlowiecDivision of Transplant Surgery, Mayo Clinic, Phoenix, AZ 85054, USA.ORCID 0000-0001-7860-9519
Michael A MaoDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Jacksonville, FL 32224, USA.ORCID 0000-0003-1814-7003
Napat LeeaphornRenal Transplant Program, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO 64108, USA.
Wisit KaewputDepartment of Military and Community Medicine, Phramongkutklao College of Medicine, Bangkok 10400, Thailand.ORCID 0000-0003-2920-7235
Pradeep VaitlaDivision of Nephrology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Pattharawin PattharanitimaDepartment of Internal Medicine, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand.ORCID 0000-0002-6010-0033
Supawit TangpanithandeeDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA.ORCID 0000-0001-6103-2338
Pajaree KrisanapanDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA.ORCID 0000-0002-2888-881X
Fawad QureshiDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA.
Pitchaphon NissaisorakarnDepartment of Medicine, Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Matthew CooperMedstar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC 20007, USA.
Wisit CheungpasitpornDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA.ORCID 0000-0001-9954-9711
Mayo Clinic · USMayo Clinic in Florida · USThammasat University · THGeorgetown University · USHarvard University · USJackson Memorial Hospital · USPhramongkutklao Hospital · THSaint Luke's Health System · USWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aimed to better characterize morbidly obese kidney transplant recipients, their clinical characteristics, and outcomes by using an unsupervised machine learning approach. Methods: Consensus cluster analysis was applied to OPTN/UNOS data from 2010 to 2019 based on recipient, donor, and transplant characteristics in kidney transplant recipients with a pre-transplant BMI ≥ 40 kg/m2. Key cluster characteristics were identified using the standardized mean difference. Post-transplant outcomes, including death-censored graft failure, patient death, and acute allograft rejection, were compared among the clusters. Results: Consensus clustering analysis identified 3204 kidney transplant recipients with a BMI ≥ 40 kg/m2. In this cohort, five clinically distinct clusters were identified. Cluster 1 recipients were predominantly white and non-sensitized, had a short dialysis time or were preemptive, and were more likely to receive living donor kidney transplants. Cluster 2 recipients were older and diabetic. They were likely to have been on dialysis >3 years and receive a standard KDPI deceased donor kidney. Cluster 3 recipients were young, black, and had kidney disease secondary to hypertension or glomerular disease. Cluster 3 recipients had >3 years of dialysis and received non-ECD, young, deceased donor kidney transplants with a KDPI < 85%. Cluster 4 recipients were diabetic with variable dialysis duration who either received non-ECD standard KDPI kidneys or living donor kidney transplants. Cluster 5 recipients were young retransplants that were sensitized. One-year patient survival in clusters 1, 2, 3, 4, and 5 was 98.0%, 94.4%, 98.5%, 98.7%, and 97%, and one-year death-censored graft survival was 98.1%, 93.0%, 96.1%, 98.8%, and 93.0%, respectively. Cluster 2 had the worst one-year patient survival. Clusters 2 and 5 had the worst one-year death-censored graft survival. Conclusions: With the application of unsupervised machine learning, variable post-transplant outcomes are observed among morbidly obese kidney transplant recipients. Recipients with earlier access to transplant and living donation show superior outcomes. Unexpectedly, reduced graft survival in cluster 3 recipients perhaps underscores socioeconomic access to post-transplant support and minorities being disadvantaged in access to preemptive and living donor transplants. Despite obesity-related concerns, one-year patient and graft survival were favorable in all clusters, and obesity itself should be reconsidered as a hard barrier to kidney transplantation.

Indexed as

body mass indexkidney transplantobesitytransplantation

Identifiers

PMID35743357
PMCPMC9224965
OpenAlexW4281689443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.